Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Jun 22, 2020 4:05pm

107 Views

Post# 31178127

todays trades

House Positions for C:VXL from 20200622 to 20200622

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
7 TD Sec	104,678	9,552	0.091	26,500	2,515	0.095	78,178	-7,037
79 CIBC	10,000	950	0.095	1,000	90	0.09	9,000	-860
68 Leede	1,961	176	0.09	1,528	139	0.091	433	-37
33 Canaccord	756	68	0.09	500	45	0.09	256	-23
39 Merrill Lynch	0			961	86	0.089	-961	86
19 Desjardins	0			2,000	180	0.09	-2,000	180
88 Credential	0			3,000	270	0.09	-3,000	270
85 Scotia	3,000	270	0.09	10,000	900	0.09	-7,000	630
13 Instinet	0			9,756	878	0.09	-9,756	878
9 BMO Nesbitt	0			10,000	900	0.09	-10,000	900
2 RBC	25,000	2,250	0.09	40,000	3,600	0.09	-15,000	1,350
1 Anonymous	0			40,150	3,663	0.091	-40,150	3,663
TOTAL	145,395	13,266	0.091	145,395	13,266	0.091	0	0